ArticleBlood neoplasia2025
Outcomes for ruxolitinib only versus combination with interferon in treating patients with myelofibrosis.
Katie Erdos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it